Healthcare - Biotechnology - NASDAQ - US
$ 2.71
-12.3 %
$ 8.14 M
Market Cap
-0.23
P/E
INCOME STATEMENT
0
REVENUE
-29.6 M
OPERATING INCOME
-29.8 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Moleculin Biotech, Inc.
| Revenue | 0 |
| Cost Of Revenue | 127 K |
| Gross Profit | -127 K |
| Operating Expenses | 29.6 M |
| Operating Income | -29.6 M |
| Other Expenses | 138 K |
| Net Income | -29.8 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 0.1 | 0.2 | 0.3 | 0.3 | 0.2 | 68 K | 18 K | 6.16 K | 0 |
| Gross Profit | (0.1) | (0.2) | (0.3) | (0.3) | (0.2) | 68 K | 18 K | 6.16 K | 0 |
| OPERATING INCOME | |||||||||
| Operating Expenses | 29.6 | 30.6 | 23.0 | 19.7 | 17.5 | 15.0 | 8.7 | 3.9 | 0.7 |
| Selling, General and Administrative Expenses | 10.0 | 11.7 | 8.4 | 6.8 | 6.3 | 5.3 | 4.1 | 2.4 | 0.5 |
| Research and Development Expenses | 19.5 | 19.0 | 14.4 | 12.8 | 11.0 | 9.7 | 4.5 | 1.5 | 0.3 |
| Operating Income | (29.6) | (30.6) | (23.0) | (19.7) | (17.5) | (15.0) | (8.7) | (3.9) | (0.7) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 0 | (1.6) | 0 | 0 | 0 | 0 | 0 | 43.2 K | 0 |
| Total Other Income | (0.1) | 1.6 | 7.1 | 2.4 | 4.1 | 3.1 | (1.2) | 43.4 K | 10.1 K |
| Pre-Tax Income | (29.8) | (29.0) | (15.9) | (17.4) | (13.4) | (11.9) | (9.8) | (3.9) | (0.7) |
| NET INCOME | |||||||||
| Tax Provision | 0 | (1.6) | (7.0) | (2.4) | (0.2) | 3.1 | 1.2 | 0 | (1.8) |
| Net Income | (29.8) | (27.4) | (8.9) | (15.0) | (13.2) | (11.9) | (9.8) | (3.9) | (0.7) |
| EPS | 15.1 | 14.4 | 0.32 | 1.49 | 1.84 | 2.75 | 3.17 | 2.4 | 0.31 |